載入...
Tinkering under the Hood: Metabolic Optimisation of CAR-T Cell Therapy
Chimeric antigen receptor (CAR)-T cells are one of the most exciting areas of immunotherapy to date. Clinically available CAR-T cells are used to treat advanced haematological B-cell malignancies with complete remission achieved at around 30–40%. Unfortunately, CAR-T cell success rates are even less...
Na minha lista:
| 發表在: | Antibodies (Basel) |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8167549/ https://ncbi.nlm.nih.gov/pubmed/33925949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antib10020017 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|